The fully operational expansion increases Emerald’s global capabilities, manufacturing flexibility and capacity for benzoic acid, benzaldehyde, and many downstream products.
Emerald Kalama Chemical recently announced it has completed startup of its $40 million expansion at its Rotterdam, Netherlands, site. The expansion reportedly increases the company’s global capabilities, manufacturing flexibility and capacity for Purox® B benzoic acid, Kalama® benzaldehyde, and many downstream products.
The additional operations in Rotterdam reportedly support the company’s strategic vision to sustain a leadership position in benzoic acid, benzaldehyde and downstream products.